M. Fässler

Type de document

Co-auteur

V. Wild

J.P. Vader

R. Spirig

D.E. Speiser

M. Siano

M. Risch

L. Risch

S. Ring

M. Recher

D. Radovanovic

C.I. Pérez Shibayama

R. Niederer

C. Mouton Dorey

J. Mangana

B. Ludewig

M.P. Levesque

A. Leu

M. Krolik

M. Kleinknecht

M. Joerger

J.M. Januel

O. Hasan Ali

S. Güsewell

T. Gächter

R. Frouzakis

L. Flatz

B. Elger

R. Dummer

S. Diem

C. Del Carmen Gil Cruz

C. Clarinval

F. Carina

B. Burnand

D. Bomze

N. Biller-Andorno

F. Berner

Date

Source

Serveur académique Lausannois (2)

Mot-clé

Evaluation (2) Tax assessment (2) thérapie (1) état (1) secteur des services (1) sécurité (1) recherche (1) projet (1) surveillance (1) modèle (1) anticorps (1) recherche interdisciplinaire (1) analyse (1) éthique (1) différenciation (1) point (1) biomarqueur (1) survie (1) Nursing (1) Monitoring (1) Differentiation (1) Development (1) Complement (1) Nurses (1) Treatment (1) Care (1) Inhibitors (1) Congresses (1) Methods (1) Health care reform (1)

Documents écrit par M. Fässler (2) | parle de M. Fässler (0)

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients.

M. Fässler et al. (20 févr. 2019)

Assessing the impact of DRGs on patient care and professional practice in Switzerland (IDoC) : a potential model for monitoring and evaluating healthcare reform.

V. Wild et al. (2015)